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In intact rat adipocytes hormone-sensitive lipase has been shown to be phosphorylated on serine residues 
in two different phosphorylation sites: a regulatory site phosphorylated by cyclic AMP-dependent protein 
kinase and a basal site, which does not directly affect the enzyme activity, phosphorylated by cyclic AMP- 
independent protein kinase(s) [(1984) Proc. Natl. Acad. Sci. USA 81, 3317-33211. Cyclic GMP-dependent 
protein kinase catalyzed the phosphorylation of the same two phosphorylation sites on the isolated enzyme, 
at serine residues. Both sites were phosphorylated at about the same rate, with the hormone-sensitive lipase 
activity concomitantly enhanced. 
Cyclic GMP-dependent protein kinase Hormone-sensitive lipase Phosphorylation site 
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1. INTRODUCTION 2. EXPERIMENTAL 
Adipose tissue lipolysis is hormonally regulated 
through control of the activity of hormone- 
sensitive lipase by reversible phosphorylation [ 11. 
Lipolytic hormones stimulate lipolysis through a 
cyclic AMP-dependent protein kinase catalyzed 
phosphorylation of a single serine residue in the 
hormone-sensitive lipase [2,3]. The same - 
regulatory - phosphorylation site is dephospho- 
rylated and lipolysis arrested in response to insulin 
[3]. In addition, a second - basal - phosphoryla- 
tion site rapidly equilibrates with cellular [32P]ATP 
[3,4]. The extent of phosphorylation of this site is 
not influenced by insulin and it is only associated 
with a very low, basal enzyme activity [4]. 
2.1. Materials 
In an approach to study the function of the basal 
phosphorylation we demonstrate here that cyclic 
GMP-dependent protein kinase, which previously 
has been shown to cause an activation of a lipase 
preparation from chicken adipose tissue [5], 
phosphorylates both the regulatory and the basal 
phosphorylation sites of hormone-sensitive lipase. 
[Y-~~P]ATP was synthesised as in [6]. Silicic acid 
thin-layer plates (0.25 mm) and HPTLC plates 
were obtained from Merck (FRG), cyclic GMP, 
phosphoserine, phosphothreonine, phosphotyro- 
sine and trypsin treated with diphenylcarbamyl 
chloride from Sigma (USA), and Staphylococcus 
aureus V8 protease from Miles Laboratories 
(USA). Hormone-sensitive lipase was detergent 
solubilized and purified to approx. 50% protein 
purity [7]. Cyclic GMP-dependent protein kinase 
(cGMP-PrK), approx. 70% pure, was provided by 
Dr D. Aswad and Professor P. Greengard, New 
York, and the specific protein inhibitor of cyclic 
AMP-dependent protein kinase (CAMP-PrK) from 
Professor P. Cohen, Dundee, Scotland. The 
catalytic subunit of CAMP-PrK was purified to 
homogeneity from adipose tissue [8]. 
2.2. Phosphorylation of hormone-sensitive lipase 
Hormone-sensitive lipase was incubated with 
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cGMP-PrK, approx. 0.2 pg/ml, in 4 mM 
imidazole-HCl buffer, pH 7.0, containing 0.1 mM 
[T-~~P]ATP, 1 PM cyclic GMP, 5 mM MgCl2 and 
the specific inhibitor protein of CAMP-PrK for the 
indicated time periods. Phosphorylation with 
CAMP-PrK was carried out as in [2]. The extent of 
phosphorylation of hormone-sensitive lipase was 
determined by densitometric scanning of 
autoradiographs after SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) as in [2]. 
The proteolytic digest was redissolved in 33% 
(v/v) pyridine and subjected to phosphopeptide 
mapping by two-dimensional electrophoresis-thin- 
layer chromatography (10 x 10 cm) on silicic acid 
as in [2]. The plates were autoradiographed at 
-80°C using Kodak X-Omat RP film with intensi- 
fying screen (DuPont) [lo]. 
2.4. Phosphoamino acid analysis 
2.3. Phosphopeptide mapping 
“P-phosphorylated hormone-sensitive lipase 
was obtained in a homogeneous form by SDS- 
PAGE and electrophoretic elution of the protein 
from the gel [9]. The eluted enzyme protein was 
alkylated in 10 mM iodoacetic acid as in [2] and ex- 
tensively dialysed against 0.5% (w/v) NHdHCO3 
and lyophilized. The protein was redissolved in 
0.5% (w/v) NH4HCO3 and digested with 100 
@g/ml S. aureus V8 protease for 4 h at 37°C 
followed by 20,ug/ml trypsin and 2 mM CaCl2 for 
15 h at 37°C and then lyophilized. 
32P-phosphorylated hormone-sensitive lipase 
was isolated by SDS-PAGE [9], extensively dia- 
lysed against 0.5% (w/v) N&HCOs, lyophilised 
and hydrolyzed in 6 M HCl under argon for 3 h at 
110°C. The solution was then evaporated to 
dryness and redissolved in water containing 
phosphoserine, phosphothreonine and phospho- 
tyrosine. The phosphorylated amino acids were 
separated by electrophoresis on silicic acid thin- 
layer plates (HPTLC, 10x 10 cm) at pH 1.9 in 
2.5% (v/v) formic acid and 15% acetic acid at 10 
V/cm for 10 min and 55 V/cm for 140 min. The 
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Fig. 1. Phosphorylation sites. (A) Hormone-sensitive lipase phosphorylated with cGMP-PrK and [y-32P]ATP was 
isolated by SDS-PAGE, electrophoretically eluted from the polyacrylamide gel, and digested with S. aureus V8 protease 
and trypsin before phosphopeptide mapping (section 2). For explanation of ‘regulatory’ and ‘basal’ see text. (B) 
Hormone-sensitive lipase phosphorylated by cGMP-PrK was mixed with lipase phosphorylated by CAMP-PrK and 
treated as in A. The asymmetric spot to the left of the centre on the map represents partially digested material. The 
cross indicates the point of application. 
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2.5. Other methods 
Hormone-sensitive lipase was activated by 
phosphorylation as above, except that unlabeled 
ATP was used; in controls ATP was omitted. In- 
cubations were stopped by addition of 3 vols of an 
ice-cold solution of 10 mM EDTA, 1 mM 
dithioerythritol and 0.1 mg/ml bovine serum 
albumin (crystallized, Sigma) and immediately 
assayed against 0.75 mM trioleoylglycerol as in [2]. 
The amount of CAMP-PrK and of cGMP-PrK was 
determined from the specific activity of the en- 
zymes as in [8] and [ 111, respectively. 
3. RESULTS 
3.1. Identification of phosphorylation sites 
cGMP-PrK catalyzed the incorporation of 
[32P]phosphate into two phosphopeptides (fig. 1A) 
which have been previously identified as cor- 
responding to a regulatory and a basal 
phosphorylation site in intact adipocytes [3]. Addi- 
tion of hormone-sensitive lipase phosphorylated in 
the regulatory site with CAMP-PrK [2] to lipase 
phosphorylated with cGMP-PrK and phosphopep- 
tide mapping selectively increased radioactivity in 
the ‘regulatory’ phosphopeptide labeled in fig. 1B 
(the asymmetric spot just to the right of the center 
of the chromatogram represents partially digested 
material; cf. fig. 2). This identifies one of the 
phosphopeptides that cGMP-PrK phosphorylates 
with the regulatory site which is phosphorylated by 
CAMP-PrK in vitro [2] and in intact fat cells [3]. 
The migration of the second phosphopeptide on 
the phosphopeptide map identifies it with the basal 
phosphorylation site previously demonstrated in 
intact fat cells [3]. 
After electrophoresis of a partial acid 
hydrolysate of hormone-sensitive lipase phos- 
phorylated with cGMP-PrK (see section 2) 
phosphoserine was the only phosphorylated amino 
acid residue detected in either phosphopeptide (not 
shown), in accordance with the phosphorylation of 
the same phosphopeptides in intact adipocytes [31. 
3.2. Rate of phosphorylation and activation of 
hormone-sensitive lipase activity 
As expected from phosphorylation of the 
regulatory site the enzyme activity was enhanced 
by its phosphorylation with cGMP-PrK (fig. 2A). 
282 





+ electrophwesis - -5 
Fig.2. Phosphorylation and activation of hormone- 
sensitive lipase by cyclic GMP-dependent protein kinase. 
Hormone-sensitive lipase was incubated with cGMP- 
PrK and [y-32P]ATP-Mg as in section 2. (A) At the in- 
dicated time points aliquots were analyzed for 32P incor- 
poration into hormone-sensitive lipase and for extent of 
lipase activation (section 2). (B) At 5 min (a), 20 min (b) 
and 60 min (c) samples were analyzed for relative extent 
of phosphorylation of the two phosphorylation sites: the 
lipase protein was isolated by SDS-PAGE, digested with 
S. aureus V8 protease and trypsin, and subjected to 
phosphopeptide mapping (section 2). 
Both sites were phosphorylated at about the same 
rate as demonstrated by phosphopeptide mapping 
at different time points (fig. 2B). 
The rate of phosphorylation was compared with 
that obtained with CAMP-PrK. Using the same 
amounts of cGMP-PrK and CAMP-PrK on a 
weight-basis the initial rate of phosphorylation 
with cGMP-PrK was about 30% of the 
phosphorylation with CAMP-PrK. This indicates 
that the cGMP-PrK subunit phosphorylates the 
regulatory and the basal site at about 25% of the 
rate obtained with the CAMP-PrK catalytic 
subunit. 
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4. DISCUSSION ACKNOWLEDGEMENTS 
Hormone-sensitive lipase is phosphorylated on 
two discrete sites in the intact adipocyte, one of 
which is identical to that phosphorylated by 
CAMP-PrK [2,3]. The findings here that cGMP- 
PrK can catalyze the phosphorylation of both sites 
in vitro could suggest a function for cGMP-PrK in 
the regulation of the lipase. 
Cyclic GMP-PrK and CAMP-PrK have very 
similar, but not identical substrate specificities 
[ 12,131. One of the problems in defining any 
physiological function of cyclic GMP and its pro- 
tein kinase has been to identify substrates that are 
specifically phosphorylated by the cGMP-PrK. 
The in vitro phosphorylation of the basal site of 
hormone-sensitive lipase is apparently one such 
specific phosphorylation by cGMP-PrK, which, 
moreover, occurs at a reasonably high rate. 
Although this site is phosphorylated and turns over 
rapidly in intact adipocytes [1,3,4], we have not 
been able to detect any direct changes in the extent 
of phosphorylation of this site in response to hor- 
mones .
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